Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("MIO, Tadashi")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 24 of 24

  • Page / 1
Export

Selection :

  • and

Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gelsMIO, Tadashi; XIANGDE LIU; TOEWS, Myron L et al.The Journal of laboratory and clinical medicine. 2002, Vol 139, Num 1, pp 20-27, issn 0022-2143Article

Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell lineHOSHINO, Yuma; MIO, Tadashi; NAGAI, Sonoko et al.American journal of physiology. Lung cellular and molecular physiology. 2001, Vol 25, Num 2, pp L509-L516, issn 1040-0605Article

Fibrogenic and inflammatory cytokines modulate mRNA expressions of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-3 in type II pneumocytesHOSHINO, Yuma; MIO, Tadashi; NAGAI, Sonoko et al.Respiration (Basel). 2001, Vol 68, Num 5, pp 509-516, issn 0025-7931Article

Phase I study of the combination of nedaplatin and gemcitabine in previously untreated advanced squamous cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 2, pp 325-330, issn 0344-5704, 6 p.Article

Epidermal growth factor receptor gene mutations in papillary thyroid carcinomaMASAGO, Katsuhiro; ASATO, Ryo; FUJITA, Shiro et al.International journal of cancer (Print). 2009, Vol 124, Num 11, pp 2744-2749, issn 0020-7136, 6 p.Article

Metastatic tumor in the right atriumTABUENA, Rollin P; MATSUMOTO, Hisako; MIO, Tadashi et al.Internal medicine (Tokyo. 1992). 2004, Vol 43, Num 5, pp 445-446, issn 0918-2918, 2 p.Article

Nitric oxide (NO) enhances pemetrexed cytotoxicity via NO-cGMP signaling in lung adenocarcinoma cells in vitro and in vivoNAGAI, Hiroki; YASUDA, Hiroyasu; HAK KIM, Young et al.International journal of oncology. 2012, Vol 41, Num 1, pp 24-30, issn 1019-6439, 7 p.Article

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03TERAMUKAI, Satoshi; KITANO, Toshiyuki; NAKANO, Kikuo et al.European journal of cancer (1990). 2009, Vol 45, Num 11, pp 1950-1958, issn 0959-8049, 9 p.Article

Pustular neutrophilic dermatoses and rapidly growing mycobacterium infection with bilateral cervical lymphadenopathyFUJISAWA, Akihiro; MATSUMURA, Yumi; KAMBE, Naotomo et al.Dermatology (Basel). 2005, Vol 210, Num 4, pp 353-355, issn 1018-8665, 3 p.Article

Bradykinin augments fibroblast-mediated contraction of released collagen gelsMIO, Tadashi; XIANGDE LIU; TOEWS, Myron L et al.American journal of physiology. Lung cellular and molecular physiology. 2001, Vol 25, Num 1, pp L164-L171, issn 1040-0605Article

A pilot study of mRNA expressions of 5-fluorouracil pathway genes in peripheral blood mononuclear cells and tumor tissues in patients with lung adenocarcinomaOGATA, Sho; OZEKI, Yuichi; AIDA, Shinsuke et al.Lung cancer. 2011, Vol 71, Num 2, pp 199-204, issn 0169-5002, 6 p.Article

Association of the transforming growth factor ss1 promoter polymorphism, C-509T, with smoking status and survival in advanced non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; FUJITA, Shiro et al.Oncology reports. 2011, Vol 25, Num 2, pp 377-382, issn 1021-335X, 6 p.Article

Clinical significance of epidermal growth factor receptor mutations and insulin-like growth factor 1 and its binding protein 3 in advanced non-squamous non-small cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; MISHIMA, Michiaki et al.Oncology reports. 2011, Vol 26, Num 4, pp 795-803, issn 1021-335X, 9 p.Article

Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; HATACHI, Yukimasa et al.Cancer science. 2008, Vol 99, Num 11, pp 2295-2301, issn 1347-9032, 7 p.Article

Population Pharmacokinetics/Pharmacodynamics of Erlotinib and Pharmacogenomic Analysis of Plasma and Cerebrospinal Fluid Drug Concentrations in Japanese Patients with Non-Small Cell Lung CancerFUKUDO, Masahide; IKEMI, Yasuaki; KATSURA, Toshiya et al.Clinical pharmacokinetics. 2013, Vol 52, Num 7, pp 593-609, issn 0312-5963, 17 p.Article

Differences in adverse events between 250 mg daily gefitinib and 150 mg daily erlotinib in Japanese patients with non-small cell lung cancerTOGASHI, Yosuke; MASAGO, Katsuhiro; FUJITA, Shiro et al.Lung cancer. 2011, Vol 74, Num 1, pp 98-102, issn 0169-5002, 5 p.Article

Efficacy of increased-dose erlotinib for central nervous system metastases in non-small cell lung cancer patients with epidermal growth factor receptor mutationTOGASHI, Yosuke; MASAGO, Katsuhiro; MISHIMA, Michiaki et al.Cancer chemotherapy and pharmacology. 2011, Vol 68, Num 4, pp 1089-1092, issn 0344-5704, 4 p.Article

Effect of vascular endothelial growth factor polymorphisms on survival in advanced-stage non-small-cell lung cancerMASAGO, Katsuhiro; FUJITA, Shiro; YUNG HAKU KIM et al.Cancer science. 2009, Vol 100, Num 10, pp 1917-1922, issn 1347-9032, 6 p.Article

Phase II study of carboplatin and pemetrexed in advanced non-squamous, non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0902YOUNG HAK KIM; HIRABAYASHI, Masataka; TOMIOKA, Hiromi et al.Cancer chemotherapy and pharmacology. 2012, Vol 70, Num 2, pp 271-276, issn 0344-5704, 6 p.Article

Association of Diffuse, Random Pulmonary Metastases, Including Miliary Metastases, With Epidermal Growth Factor Receptor Mutations in Lung AdenocarcinomaTOGASHI, Yosuke; MASAGO, Katsuhiro; KUBO, Takeshi et al.Cancer. 2011, Vol 117, Num 4, pp 819-825, issn 0008-543X, 7 p.Article

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancerYANAGIHARA, Kazuhiro; YOSHIMURA, Kenichi; MISAWA, Akiko et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 5, pp 913-918, issn 0344-5704, 6 p.Article

Clinical Significance of Pretreatment C-Reactive Protein in Patients with Advanced Nonsquamous, Non-Small Cell Lung Cancer Who Received GefitinibMASAGO, Katsuhiro; FUJITA, Shiro; MIO, Tadashi et al.Oncology. 2010, Vol 79, Num 5-6, pp 355-362, issn 0030-2414, 8 p.Article

Postoperative complications after induction chemoradiotherapy in patients with non-small-cell lung cancerFUJITA, Shiro; KATAKAMI, Nobuyuki; TAKAHASHI, Yutaka et al.European journal of cardio-thoracic surgery. 2006, Vol 29, Num 6, pp 896-901, issn 1010-7940, 6 p.Article

Fibroblast contractility : Usual interstitial pneumonia and nonspecific interstitial pneumoniaMIKI, Hiroyuki; MIO, Tadashi; NAGAI, Sonoko et al.American journal of respiratory and critical care medicine. 2000, Vol 162, Num 6, pp 2259-2264, issn 1073-449XConference Paper

  • Page / 1